{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T09:59:28Z","timestamp":1763978368106,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejphar.2023.176216","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T18:20:26Z","timestamp":1701282026000},"page":"176216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Edoxaban treatment in a post-infarction experimental model"],"prefix":"10.1016","volume":"962","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1334-688X","authenticated-orcid":false,"given":"Javier","family":"Mart\u00ednez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Almengl\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Babarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-9135","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Iglesias-Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1s","family":"Garc\u00eda-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel L.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Souto-Bayarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-8425","authenticated-orcid":false,"given":"Ezequiel","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176216_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.hlc.2012.11.016","article-title":"The role of cardiac magnetic resonance imaging (MRI) in acute myocardial infarction (AMI)","volume":"22","author":"Ahmed","year":"2012","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ejphar.2023.176216_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115970","article-title":"Exercise training reduces cardiac dysfunction and remodeling in ovariectomized rats submitted to myocardial infarction","volume":"9","author":"Almeida","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176216_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114063","article-title":"Edoxaban's contribution to key endothelial cell functions","volume":"178","author":"Almenglo","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176216_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cardfail.2009.01.007","article-title":"Left ventricle radio-frequency ablation in the rat: a new model of heart failure due to myocardial infarction homogeneous in size and low in mortality","volume":"15","author":"Antonio","year":"2009","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2023.176216_bib5","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2002-03-0954","article-title":"Coagulation activation and long-term outcome in acute coronary syndromes","volume":"102","author":"Ardissino","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.176216_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","author":"Capodanno","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2023.176216_bib7","first-page":"115","article-title":"Study on the expression of VEGF and HIF-1alpha in infarct area of rats with AMI","volume":"20","author":"Cheng","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2023.176216_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2022.01.014","article-title":"Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: rationale and design of the randomized EPIC-CAD trial","volume":"247","author":"Cho","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2023.176216_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jprot.2016.11.017","article-title":"Quantitative proteomic changes during post myocardial infarction remodeling reveals altered cardiac metabolism and Desmin aggregation in the infarct region","volume":"152","author":"Datta","year":"2017","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.ejphar.2023.176216_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/fca-2021-0120","article-title":"Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis","volume":"18","author":"Deitelzweig","year":"2022","journal-title":"Future Cardiol."},{"key":"10.1016\/j.ejphar.2023.176216_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12968-018-0468-5","article-title":"Non-contrast assessment of microvascular integrity using arterial spin labeled cardiovascular magnetic resonance in a porcine model of acute myocardial infarction","volume":"20","author":"Do","year":"2018","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ejphar.2023.176216_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/14740338.2019.1578344","article-title":"Safety of direct oral anticoagulants in real-world clinical practice: translating the trials to everyday clinical management","volume":"18","author":"Fawzy","year":"2019","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2023.176216_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCRESAHA.120.317219","article-title":"Different DOACs control inflammation in cardiac ischemia-reperfusion differently","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176216_bib14","first-page":"404","article-title":"Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction","volume":"19","author":"Garg","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ejphar.2023.176216_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2342-10-1","article-title":"Design and validation of Segment--freely available software for cardiovascular image analysis","volume":"10","author":"Heiberg","year":"2010","journal-title":"BMC Med. Imag."},{"key":"10.1016\/j.ejphar.2023.176216_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00395-018-0685-y","article-title":"Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis","volume":"113","author":"Hou","year":"2018","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2023.176216_bib17","first-page":"1473","article-title":"Myocardial interstitial fibrosis - histological and immunohistochemical aspects","volume":"56","author":"Istratoaie","year":"2015","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.ejphar.2023.176216_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183323","article-title":"Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats","volume":"12","author":"Kainuma","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176216_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.176216_bib20","first-page":"e9349","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2023.176216_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCULATIONAHA.107.723262","article-title":"Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial","volume":"117","author":"Kim","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.176216_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2006.11.026","article-title":"Surgical animal models of heart failure related to coronary heart disease","volume":"74","author":"Klocke","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2023.176216_bib23","article-title":"Immunohistochemical analysis of vimentin expression in myocardial tissue from autopsy cases of ischemic heart disease","volume":"54","author":"Kondo","year":"2022","journal-title":"Leg. Med."},{"key":"10.1016\/j.ejphar.2023.176216_bib24","first-page":"2555","article-title":"MiR-34a regulates cell apoptosis after myocardial infarction in rats through the Wnt\/beta-catenin signaling pathway","volume":"23","author":"Li","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2023.176216_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lfs.2008.06.016","article-title":"Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats","volume":"83","author":"Lin","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.176216_bib26","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2023.176216_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197583","article-title":"Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: systematic review and meta-analysis","volume":"13","author":"Makam","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176216_bib28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/CIRCULATIONAHA.113.002863","article-title":"Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction","volume":"128","author":"Malliaras","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.176216_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1160\/TH07-07-0443","article-title":"Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test","volume":"99","author":"Orbe","year":"2008","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2023.176216_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.11091882","article-title":"Delayed contrast enhancement on MR images of myocardium: past, present, future","volume":"261","author":"Ordovas","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ejphar.2023.176216_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2014.09.030","article-title":"Aminoguanidine inhibits ventricular fibrosis and remodeling process in isoproterenol-induced hypertrophied rat hearts by suppressing ROS and MMPs","volume":"118","author":"Parthasarathy","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.176216_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.44.4.503","article-title":"Myocardial infarct size and ventricular function in rats","volume":"44","author":"Pfeffer","year":"1979","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176216_bib33","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1097\/MJT.0000000000000913","article-title":"Anticoagulation in acute coronary syndrome: review of major therapeutic advances","volume":"26","author":"Pop","year":"2019","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.ejphar.2023.176216_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/504037","article-title":"Long-term left ventricular remodelling in rat model of nonreperfused myocardial infarction: sequential MR imaging using a 3T clinical scanner","volume":"2012","author":"Saleh","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2023.176216_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000368747","article-title":"Role of oral factor Xa inhibitors after acute coronary syndrome","volume":"129","author":"Sharma","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ejphar.2023.176216_bib36","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/TP.0b013e31822d875c","article-title":"Establishing new porcine ischemic cardiomyopathy model by transcatheter ischemia-reperfusion of the entire left coronary artery system for preclinical experimental studies","volume":"92","author":"Shudo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ejphar.2023.176216_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2023.176216_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006511","article-title":"Cardiovascular- and bleeding-related Hospitalization rates with edoxaban versus warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial","volume":"13","author":"Vilain","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejphar.2023.176216_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3892\/etm.2022.11513","article-title":"IL-6 inhibitors effectively reverse post-infarction cardiac injury and ischemic myocardial remodeling via the TGF-beta1\/Smad3 signaling pathway","volume":"24","author":"Wang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2023.176216_bib40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40266-017-0466-6","article-title":"Appropriateness of oral anticoagulants for the long-term treatment of atrial fibrillation in older people: results of an evidence-based review and international consensus validation process (OAC-FORTA 2016)","volume":"34","author":"Wehling","year":"2017","journal-title":"Drugs Aging"},{"year":"2020","series-title":"Global Health Estimates 2019: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019","key":"10.1016\/j.ejphar.2023.176216_bib41"},{"key":"10.1016\/j.ejphar.2023.176216_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-018-0463-x","article-title":"Quantification of myocardial infarct area based on TRAFFn relaxation time maps - comparison with cardiovascular magnetic resonance late gadolinium enhancement, T1rho and T2 in vivo","volume":"20","author":"Yla-Herttuala","year":"2018","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ejphar.2023.176216_bib43","first-page":"176","article-title":"Edoxaban in atrial fibrillation patients with established coronary artery disease: insights from ENGAGE AF-TIMI 48","volume":"8","author":"Zelniker","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923007306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:25:07Z","timestamp":1762143907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923007306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S0014299923007306"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176216","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Edoxaban treatment in a post-infarction experimental model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176216"}}